Target intelligence / Profile preview

Host-microbiota ecosystem and intestinal epithelial barrier

Molecular classification
Other
01

Overview

The host-microbiota ecosystem and intestinal epithelial barrier constitute a dynamic interface that separates the internal environment from the external luminal contents. This system includes a physical barrier of epithelial cells joined by tight junctions, a chemical barrier of mucus and antimicrobial peptides, and a diverse microbial community that interacts with the host immune system (Vancamelbeke & Vermeire, 2017). The microbiota plays a crucial role in fermenting dietary fibers into short-chain fatty acids, which serve as energy for colonocytes and maintain barrier integrity (Thursby & Juge, 2017). Disruptions to this ecosystem, known as dysbiosis, can lead to increased intestinal permeability, allowing the translocation of pro-inflammatory molecules like lipopolysaccharides into the bloodstream (Chelakkot et al., 2018). This "leaky gut" state is associated with various conditions, including inflammatory bowel disease, metabolic syndrome, and certain autoimmune disorders. Therapeutic interventions focus on restoring this balance through probiotics, prebiotics, or fecal microbiota transplantation to reinforce the barrier and modulate the host's immune response. Additionally, pharmacological agents like mucosal protectants and specific antibiotics are used to manage the microbial environment and protect the epithelial lining. Understanding the cross-talk between host cells and the microbiome is essential for developing targeted therapies for chronic inflammatory and metabolic diseases.

Other names
Gut barrierIntestinal mucosal barrierHost-microbiome interfaceGut-microbiota axis
02

Mechanism of action

Modulation of microbial composition, enhancement of tight junction protein expression, and regulation of mucosal immune cell activity.

03

Biological functions

Immune responseMetabolismBarrier functionHomeostasisSignal transduction
04

Disease associations

Inflammatory bowel diseaseIrritable bowel syndromeMetabolic syndromeObesityAutoimmune diseaseInfection
05

Safety considerations

Risk of systemic infectionDysbiosisUnpredictable response to fecal microbiota transplantLack of standardization
06

Interacting drugs

Probiotics

6 more in the full profile.

07

Biomarkers

ZonulinCalprotectinShort-chain fatty acidsLipopolysaccharide16S rRNA sequencing

Beyond the preview

Go deeper on Host-microbiota ecosystem and intestinal epithelial barrier.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host-microbiota ecosystem and intestinal epithelial barrier.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call